Heart Health

Outsmarting Obesity with Dr. Stewart Lonky

 
Dr. Stewart Lonky, a renowned figure in the fight against obesity, with nearly four decades of experience in clinical, academic, and laboratory settings joins eHealth Radio and the Health News and Weight Management Channels. He is the founder and medical director of West Coast Cardiopulmonary, Inc., and maintains a thriving medical practice.
Listen to interview with host Eric Michaels & guest Dr. Stewart Lonky discuss the following:
In your book, Outsmarting Obesity, you write extensively about the Healthy At Every Size Movement (HAES). Can you explain what the "Healthy at Every Size" (HAES) movement is, especially for those who might not be familiar with it?
Your book "Outsmarting Obesity" addresses the obesity epidemic. Can you briefly outline the key concerns or challenges contributing to this issue?
Are there studies or evidence suggesting any limitations or challenges with the HAES philosophy in promoting long-term health outcomes?
What are your main critiques of the "Healthy at Every Size" (HAES) movement, especially in the context of managing and addressing obesity?
What adjustments or considerations would you recommend for public health strategies to address both obesity and the principles of body positivity effectively?
Dr. Stewart Lonky, a practicing physician specializing in internal medicine, pulmonary medicine and critical care, with a biochemistry background and a 10 year career at UCSD medical school and now in private practice for 35 years.
Dr. Lonky has a strong background in toxicology and legal medicine and also has an MBA from Pepperdine University and has served as Chief Medical Officer and Regulatory Affairs Director for a medical device company. He has a strong research background, facing problems with patients who are getting more obese, year after year, compromising my ability to care for them as outpatients and as inpatients.
Website: https://drlonky.com
Social Media Links: Instagram: https://instagram.com/stewartlonkymd Facebook: https://www.facebook.com/stewartlonkymd X: https://x.com/LonkyMD
People also listened to this: Housing Transitions for Seniors with Nelly Some

HeartSecure: Empowering People with Affordable Cardiac Screenings At-Home

 
Dr. Waqaas Al-Siddiq, CEO and Founder of Biotricity joins eHealth Radio and the Health News and Heart Health Channels. Dr. Al-Siddiq is recognized as a leader and innovator in the healthcare space, frequently speaking and publishing on thought-provoking topics in healthcare, such as AI and the democratization of quality medical care.  
Listen to interview with host Eric Michaels & guest Dr. Waqaas Al-Siddiq discuss the following:
Why should listeners take a moment to think about their heart health, especially those who don’t have a known history of heart disease?    
Why is heart disease still the number 1 killer in the world with all our technology and resources? 
We have so many digital health wearables, why cant we just use them to figure out our heart health? 
Can you discuss the importance of preventative care?
How does Biotricity’s direct-to-consumer heart health screening service, HeartSecure, help users maintain their overall health through this preventative approach? 
Healthcare accessibility remains a prominent issue in the U.S. today. How does HeartSecure address the issue of healthcare accessibility disparities?  
Dr. Waqaas Al-Siddiq, CEO and founder of Biotricity, is a leader in healthcare and innovation. He is recognized internationally as a serial entrepreneur, former investment advisor, an expert in corporate strategy, and an innovative technologist.
Waqaas is deeply vested in the potential that IoT-connected technology, enhanced with AI, could bring to healthcare. He is often a guest or keynote speaker at major conferences, podcasts, and media outlets, including Forbes, Bloomberg, Fox, CNBC, and Yahoo! Waqaas frequently speaks and publishes on thought-provoking topics such as AI, the implementation of new technologies into the healthcare sphere, and the development of medical devices for underserved communities.
Waqaas has been distinguished for his various state-of-the-art designs in digital, analog, embedded, and micro-electro-mechanical products. He has held several high-level design positions at IBM, AMD, and Intel. Additionally, he has vast experience leading various groups through his board experience and executive roles within start-ups, mid-sized companies, and non-profits. Waqaas has raised over $150M as an entrepreneur and built companies recognized as leaders in their space, successfully commercializing over 15 products in multiple countries.
Website: https://www.biotricity.com 
Social Media Links: Facebook: https://www.facebook.com/biotricity X: https://twitter.com/biotricity_incLinkedin: https://www.linkedin.com/company/biotricity
People also listened to this: Expert-Backed Solutions: Your Key to Reliable Health Remedies

Lower Your Risk of Heart Disease With Enzymes

 
Dr. Ellen Cutler a chiropractor that specializes in the use of desensitization of food and other sensitivities, gentle detoxification, and enzyme and nutritional therapies for chronic conditions that have perplexed the conventional medical establishment again joins eHealth Radio and the Health News & Heart Health Channels.
Listen to interview with host Eric Michaels and guest Dr. Ellen Cutler discuss the following:
Can you provide an overview of how enzyme therapy, as detailed in your book "MicroMiracles," plays a crucial role in lowering the risk of heart disease? How do enzymes contribute to heart health, and can you share any success stories from individuals who have benefited from this approach?
In your Ellen Cutler Method (ECM), you emphasize organ-specific detoxification, enzymes, nutrition, and energetic desensitization. Could you explain how each of these components works together to improve heart health? Additionally, are there specific dietary recommendations within ECM that listeners can adopt to enhance their cardiovascular well-being?
Given the prevalence of heart disease and its impact on both men and women, can you highlight any key differences or considerations in implementing enzyme therapy and lifestyle changes for heart health in women? Are there specific challenges or benefits that women might experience in comparison to men?
Your approach to heart disease prevention suggests a potential reduction or elimination of dependence on medications. Could you elaborate on how enzyme therapy and your program may complement or replace conventional medications for conditions like high blood pressure and high cholesterol? What advice do you have for individuals currently on medication but looking to explore alternative approaches?
As we focus on Heart Month, what actionable steps or lifestyle changes can listeners take to immediately start improving their heart health? Are there simple yet effective practices or habits that you recommend for someone looking to proactively reduce their risk of heart disease based on your expertise in enzyme therapy and the ECM?
Dr. Ellen Cutler is a bestselling author and an internationally recognized teacher, public speaker, and media spokesperson. Her books include "MicroMiracles — Discover the Healing Power of Enzymes," now available in a revised, expanded edition. She has a chiropractic degree and specializes in the use of desensitization to food and other sensitivities, gentle detoxification, and enzyme and nutritional therapies for chronic conditions that have perplexed the conventional medical establishment. This is all addressed in her revolutionary healing technique ECM (Ellen Cutler Method).
Website: https://drellencutler.com
Social Media Links: Linkedin: https://linkedin.com/in/drellencutler  Facebook: https://facebook.com/MicroMiraclesEnzymes  Instagram: https://instagram.com/ellencutlerdc  Twitter: https://twitter.com/drellencutler  Youtube: https://www.youtube.com/c/EllenCutler 
People also listened to this: Discussing Facelifts with Dr. Bajaj

Keeping your Heart Healthy with Krill Oil

 
 
Dr. Yunpeng Ding, PhD, and Director R&D of Human Nutrition at Aker BioMarine, a biotech innovator and supplier of Superba Krill, the world’s leading krill oil ingredient joins eHealth Radio and the Heart Health and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Yunpeng Ding discuss the following:
Why is heart health important at various stages in life?
What are current trends in heart health?
What is krill oil and why is it important for heart health?
Is it true that heart health is connected to liver health?
What is the key takeaway for our listeners about heart health?
Dr. Yunpeng Ding is a senior researcher, currently serving as R&D Director in the Innovation team at Aker Biomarine. He supervises clinical research on the health benefits of omega-3 fatty acids for the company’s human nutrition product – krill oil. Before joining Aker BioMarine in 2020, Dr. Ding served as chief biostatistician for a European CRO in pharmaceutical industry where he was responsible for designing, analyzing, and reporting multiple Phase I-III clinical trials.
He obtained his medical degree from China in 2008, MSc Public Health in 2011, and PhD in Epidemiology and Biostatistics from University of Bergen, Norway in 2016.
Website: https://www.superbakrill.com Linkedin: https://www.linkedin.com/showcase/superbakrill 
People also listened to this: Impacting Healthcare: ASAAR Medical’s Accountable Care Organization Reach Program

HeartBeam: The First 12-lead medical grade heart attack detection that’s personal, portable, and easy-to-use

 
 
Branislav Vajdic, PhD, and the Chief Executive Officer and Founder of HeartBeam, Inc. joins eHealth Radio and the Heart Health and Health News Channels. HeartBeam is the first 12-lead medical grade heart attack detection that's personal, portable, and easy-to-use.
Listen to interview with host Eric Michaels and guest Dr. Branislav Vajdic discuss the following:
Please tell us about your background and why you launched HeartBeam. We'd love to hear more about how this device is being used for the first time outside of a medical setting, and what makes it different from what's currently available.
According to the American Heart Association, more people die from heart attacks during the last week of December than at any other time of the year.  How is HeartBeam positioned to slow this trend in terms of saving lives, trips to the hospitals, and how it helps people know if they are having a heart attack?
How will HeartBeam impact patients in remote areas and what does this mean for virtual medicine?
HeartBeam is being tested and in trials. Can you tell us a bit more? Where is HeartBeam currently being used? What has been the feedback from doctors and patients?
What's next for HeartBeam in 2023 and even in 2024?
Branislav Vajdic, PhD, Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the Company.
Prior to HeartBeam from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management positions. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs.
Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is the author of numerous patents and publications in the fields of cardiovascular devices as well as chip design.
Website: https://www.heartbeam.com 
Social Media Links: Twitter: https://twitter.com/HeartBeamInc  LinkedIn: https://linkedin.com/company/heartbeam-inc 
People also listened to this: Mental Health for Teens with Ken Baum

The Heart of the Matter: How to Protect Yourself Against Heart Disease

 
 
Bryant Lusk a military veteran, health advocate and author of his latest book "Heart Disease & Hypertension: Vitamin Therapy™ for a Healthy Heart" joins eHealth Radio and the Heart Health & Health News Channels.
Listen to host Eric Dye & guest Bryant Lusk discuss the following:
What prompted you to write about this subject?
What makes your book unique compared to others regarding heart disease or hypertension?
What are the three categories of risk factors for heart disease?
Can diet alone prevent heart disease and what are your feelings regarding food vs supplements?
How can one identify nutritional needs to protect against heart disease?
What nutritional supplements are most beneficial? Is there a danger in taking some supplements?
How does sleep affects heart disease?
What is the connection between the mind (emotions, stress, etc.) and the heart?
Bryant Lusk is a military veteran, author and health advocate. He grew up on the South Side of Chicago. Despite the challenges of gang violence and poverty, he became a successful Safety Inspector and Quality Control Specialist with the United States Government. Lusk spent four years in the United States Air Force, learning the true meaning of empowerment and pride. His desire to serve and protect others led him to begin writing his Share the Health book series, aiming to treat debilitating conditions. His latest book is: Heart Disease & Hypertension: Vitamin Therapy™ for a Healthy Heart (Koehlerbooks, May 2022).
 
 
Website: https://bryantlusk.com 
Social Media Links: Linkedin: https://linkedin.com/in/bryantlusk  Twitter: https://twitter.com/NotTheCans 

BioSig Technologies increases efforts in Electrophysiology and Atrial Fibrillation

 
 
Ken Londoner, the Chief Executive Officer, Founder and Director of BioSig Technologies that is working to develop and deliver the advanced signal processing solutions that will unlock the future of bio-electronic medicine, starting with the PURE EP™ System joins eHealth Radio and the Heart Health and Technology Channels.
Listen to interview with host Eric Michaels and guest Ken Londoner discuss the following:
Tell us a little bit about BioSig, the company’s mission and its efforts with in the medtech industry.
What does PURE EP help treat?
What types of current technologies are being used to treat AFib and how does your technology differ?
How is BioSig’s PURE EP reshaping the future of electrophysiology? How will this technology be used in hospitals, electrophysiology labs, and other institutions?
Tell us a little about BioSig’s subsidiary, ViralClear, and its potential antiviral candidate to treat COVID-19 patients.
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company’s first product, PURE EP(tm) System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.
 
 
Website: www.biosig.com
Social Media Links: Facebook: facebook.com/biosigtechnologies Linkedin: linkedin.com/company/biosig-technologies-inc- Twitter: twitter.com/BioSig_Tech

The importance of accurate and precise blood volume measurement in heart failure and critical care patients

 
Michael Feldschuh, the CEO of Daxor, an innovative medical instrumentation and biotechnology company focused on blood volume measurement joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Michael Feldschuh discuss the following:
Can you tell me a bit about yourself and how you got interested in the medical technology field that led to your involvement with Daxor?
Let’s talk about BVA-100 and its benefits to physicians? How does BVA-100 differentiate from other similar technologies?
How does BVA-100 allow clinicians to provide better outcomes for their patients?
Are there any recent studies that validate BVA?
Please give us an overview of BVA-100 and how it improves outcomes for heart failure patients?
Daxor Corporation (NYSE: DXR) is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology has the potential to improve hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved patient outcomes. Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.
 
 
Website: www.daxor.com
Social Media Links: Facebook: facebook.com/Daxorcorp  Linkedin: linkedin.com/company/daxorcorporation  Twitter: twitter.com/DaxorBVA

Biotricity on a Mission to Protect Your Heart

 
 
Dr. Waqaas Al-Siddiq, PhD the Founder and CEO of Biotricity a developer of advanced remote cardiac monitoring technology joins eHealth Radio and the Heart Health and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Waqaas Al-Siddiq discuss the following:
What is Biotricity’s mission?
What is the problem you are solving?
How does Biotricity benefit doctor and their patients?
How do the Biotricity Bioflux and Biocentrix products work?
With the increase in stress and anxiety related to Covid-19, how can Biotricity reduce the problem?
 
 
Trying to maintain a healthy heart has become more difficult in the wake of COVID-19. While the pandemic has increased remote tele-health, there are glaring vulnerabilities due to a lack of real-time cardiac monitoring. Heart attacks are on the rise as a result of patients ignoring symptoms, staying home and not going to the hospital. COVID related stress has caused a surge in cardiac health issues. Additionally, some recovering COVID patients have since developed heart issues related to the virus. As a result, the need for real-time cardiac monitoring is more important than ever.
Dr. Waqaas Al-Siddiq has been at the forefront of remote monitoring solutions. He is the founder and CEO of Biotricity, developer of advanced remote cardiac monitoring technology. Waqaas believes COVID-19 has accelerated the ongoing shift in the health landscape from a reactive system to a prevention, personalized and more efficient tech-based system.
Waqaas, is a serial entrepreneur, a former investment advisor and an expert in wireless communication technology. Academically, he was distinguished for his various innovative designs in digital, analog, embedded, and micro-electro-mechanical products. His work was published in various conferences such as IEEE and the National Communication Council.
Waqaas has held several high-level design positions in IBM, AMD, and Intel. His achievements have been numerous in both the technical and academic world. Coupled with this, Waqaas has vast experience in leading various groups through his board experience and executive roles within start-ups, mid-sized companies, and non-profits.
Waqaas has a dual Bachelor’s degree in Computer Engineering and Economics, a Master’s in Computer Engineering from Rochester Institute of Technology, and a Master’s in Business Administration from Henley Business School. He also holds a Doctorate in Business with a specialty in Transformative Innovations and Billion Dollar Markets.
 
 
Website: https://www.biotricity.com
Social Media Links: Facebook: facebook.com/biotricity Linkedin: linkedin.com/company/biotricity-measuring-vitals  Twitter: twitter.com/biotricity_inc

Heart issues and the full range of heart-related illnesses people need to be aware of

 
 
Dr. Rishin Shah, a Texas-based cardiologist who is triple-certified with board certifications in cardiovascular medicine, internal medicine, and interventional cardiology again joins eHealth Radio and the Heart Health & Health News Channels.
 
Listen to interview with host Eric Michaels and guest Dr. Rishin Shah discuss the following:
How many people die from heart related illnesses each year (17 million, more than cancer, HIV and malaria combined).
Why are we still seeing so many heart-related illnesses and death when there is so much medical information available?
What are the top three things a person can do to protect their heart health?
What if you have a family history of heart illness? Is there anything you can do to prevent an issue?
What's going on in the world of treatments and surgeries for heart illness patients? Are there breakthroughs or progress to report?

Dr. Rishin Shah, MD, has over 10 years of experience treating cardiovascular conditions and is a renowned cardiologist. He believes prevention is key to maintaining health and specializes in finding the least minimally invasive treatment options for his patients to get them back to optimal health.
At his practice, Prime Heart and Vascular, with locations in Plano, Frisco, and Allen, Texas, Dr. Shah is committed to serving his patients and the surrounding communities. He has expert knowledge in understanding the complications that arise at any age and provides state-of-the-art care so patients live longer, more fulfilling lives.
Cardiovascular conditions can be scary. Dr. Shah is committed to fostering a safe, welcoming, and compassionate environment for his patients at Prime Heart and Vascular, taking the necessary time to explain all aspects of procedures, conditions, and treatments. As a patient, you’re part of the family. And Dr. Shah’s core values provide care from the H.E.A.R.T.: hospitality; empathy and enthusiasm; attitude; respect; and teamwork. Dr. Shah received his medical degree from Saint Louis University School of Medicine and is board-certified in cardiovascular medicine, internal medicine, and interventional cardiology.
 
 
Website: www.primehv.com Blog: www.primehv.com/blog  Reviews: www.primehv.com/testimonials  Facebook: facebook.com/pages/Prime-Heart-and-Vascular